SNORA24 and neoplasm: In a hepatocellular carcinoma model driven by oncogenic RAS, McMahon and colleagues demonstrated that this loss of translational fidelity enables cells to bypass oncogene-induced senescence, thereby allowing tumor development and validating SNORA24 as tumor suppressor [19].